What Evidence Is Guiding Your AI Investment? | DRIVE™ · NeuroAIQ

DRIVE™ Adaptability Diagnostic · NeuroAIQ

What evidence tells you your AI investment will succeed?

The conditions inside your organisation determine whether AI investment delivers business value. DRIVE™ reveals and measures them, so you invest with evidence, not in the fog.

Right now, you’re investing in the fog.

AI budgets approved without evidence. Rollouts scaled before the conditions are ready. Value assumed, never measured.

What it costs to decide blind

The bill arrives whether you see it or not.

Ghost Seat Software Bleed

You buy 500 AI licences. Half go unused.

The spend is committed on multi-year contracts, whether people adopt or not.

Pilot Purgatory

A pilot runs 18 months and never scales.

The subscription keeps billing while the return never arrives.

Shadow AI

Staff route around approved tools.

Company data leaves with them, and the exposure has no ceiling.

The AI ROI Trap

The board asks for ROI. You can’t show it.

Confidence in the AI mandate erodes, and the next investment is cut.

The way through

DRIVE™ clears the fog.

Invest with confidence.

In 3 weeks, DRIVE™ shows you where your AI investment will create business value, and what’s standing in the way, by assessing your organisational environment.

Maximise AI ROI

Direct investment where it’s most likely to create business value.

Reduce investment risk

Identify the organisational barriers that undermine adoption, before they cost you.

Prioritise your AI investment

Know where to invest first for the greatest return.

Support board decisions

Bring credible evidence into AI investment discussions.

DRIVE™ measures the organisational environment, the LEAD™ link where an organisation’s adaptability determines whether AI investment becomes business value. Part of NeuroAIQ’s adaptability ecosystem.

What is DRIVE™

The DRIVE™ Diagnostic, defined.

DRIVE™ measures the organisational conditions that determine whether AI investment delivers business value.

5 stages. Engage the first 2 on their own, or all 5 for a complete assessment and a prioritised plan.

3-weekD

Discover

Operational pain points

3-weekR

Reveal

Brain responses

12-weekI

Intelligence

Risk mapping

12-weekV

Value

Prioritisation

12-weekE

Execution

Priorities

Tier 1 · Standalone

Discovery

3 weeks · Discover & Reveal stages

Identify the organisational conditions affecting AI adoption before you commit further investment.

What you leave with

  • Which operational problems to solve first, the friction your managers can’t see.
  • Why previous interventions didn’t stick, the human response holding the friction in place.
Start with Discovery

Tier 2 · Complete assessment

Full Diagnostic

12 weeks · Discover, Reveal, Intelligence, Value & Execution stages

A complete organisational assessment across all 5 DRIVE™ stages, culminating in prioritised execution recommendations.

Adds, on top of Discovery

  • Where adaptability risk concentrates across roles and workflows, before it derails a rollout.
  • Where to invest first for the greatest adoption and performance return.
  • A defensible fund-first / next / later sequence, with evidence behind every call.
Scope the Full Diagnostic

When to use DRIVE™

Organisations use DRIVE™ when they need to:

  • Improve AI adoption across the organisation
  • Increase AI ROI and business value
  • Reduce Shadow AI and strengthen AI governance
  • Improve AI licence utilisation
  • Identify organisational readiness for AI
  • Prioritise AI investment and implementation
  • Prepare the workforce for AI adoption
  • Identify the barriers to AI adoption and business value

Case study

The barriers metrics never showed.

We partnered with a management team struggling with adoption to understand why it kept stalling. Through our diagnostic, we identified 62 operational pain points their metrics never showed, and traced the organisational conditions holding adoption back.

Executive findings

62Operational pain points
68%Caused by organisational conditions
78%Still using our tools by Day 16
3Brain-response patterns mapped
Challenge

Why adoption stalled

A management team was struggling with adoption. We partnered with them to find the cause.

Key findings

62 hidden barriers

We identified 62 operational pain points their metrics never showed, the organisational environment holding adoption back.

What the assessment revealed

Mapped to the brain

Using the LEAD™ framework, we mapped these to the workforce’s adaptive brain responses, and identified the three patterns driving low adoption.

Business implications

Structural, not resistance

68% of the low adoption came from structural organisational conditions, not individual resistance to change.

Outcome

Behaviour, not awareness

By Day 16, 78% of participants were still using our tools, a shift in behaviour, not just awareness, moving toward stronger adoption.

“It improved my efficiency and the quality of my outputs. I have already seen a positive impact in my daily work.”

Senior leadership

“Enjoyed the scientific approach to helping manage barriers when under pressure, it gave me permission to protect time for important tasks.”

Operational delivery

Findings from a NeuroAIQ engagement, anonymised. Figures are the client’s own, from a measured post-engagement follow-up.

Before you engage

DRIVE™, answered.

What is DRIVE™ and how does it work?
DRIVE™ is NeuroAIQ’s organisational environment assessment. It measures the organisational conditions that determine whether AI investment delivers business value, across 5 stages, Discover, Reveal, Intelligence, Value and Execution. Rather than surveying opinions, it assesses the environment against a structured framework and returns evidence executives can act on.
How do the 3-week and 12-week DRIVE™ engagements differ?
Discovery (3 weeks) runs stages D + R: it identifies which operational problems to solve first and why previous interventions didn’t stick. Full Diagnostic (12 weeks) runs all 5 stages, adding where adaptability risk concentrates, where to invest first, and a defensible fund-first / next / later execution sequence. Discovery stands on its own; the Full Diagnostic is the complete assessment.
What outcomes and executive deliverables will we receive?
From Discovery: a clear view of the friction managers can’t see, and the human responses holding it in place. From the Full Diagnostic: a map of where adaptability risk concentrates, a prioritisation of where to invest first, and a board-ready fund-first / next / later plan with evidence behind every call.
How is DRIVE™ different from a traditional AI readiness assessment or employee survey?
Surveys report opinions and satisfaction scores. DRIVE™ assesses the organisational environment against a structured, neuroscience-informed framework and returns decision-grade evidence, what’s breaking, why, and what to do about it, not a self-reported readiness rating.
When should an organisation engage DRIVE™?
Before committing significant AI investment, before scaling a rollout, or when adoption and ROI are falling short of the business case. DRIVE™ is designed to run before the spend is committed, so the decision is made on evidence rather than assumption.
Who should participate in the assessment?
DRIVE™ is an executive decision tool, sponsored at leadership level, drawing on the managers and teams inside the scope being assessed. A discovery conversation defines the scope, the participants and the business question the assessment needs to answer.
How do the findings support future AI investment decisions?
DRIVE™ turns organisational conditions into board-ready evidence: where AI investment is most likely to create value, where the barriers are, and a prioritised sequence for action. That lets executives direct capital with confidence and defend the decision in an investment or board discussion.

Invest with evidence.

DRIVE™ gives you the evidence behind your AI investment, where it’s creating business value, and where it isn’t.